Complete Up To Date Information about Hylartin V.
NADA Number: 112-048 | |
| Proprietary Name |
Hylartin® V Hylartin® V Injection |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Hyaluronate Sodium |
| Species |
Horse, not for meat production |
| Routes of Administration |
Intra-articular |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.1145 Hyaluronate sodium. Specifications: Each milliliter of sterile aqueous solution contains 10 milligrams of hyaluronate sodium. Conditions of use: Horses Amount: Small and medium-size joints (carpal, fetlock)-20 milligrams; larger joint (hock)-40 milligrams. Indications: Treatment of joint dysfunction in horses due to noninfectious synovitis associated with equine osteoarthritis. Limitations: For intra-articular injection in horses only. Treatment may be repeated at weekly intervals for a total of three treatments. Do not use in horse intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |